Because it hits multiple melanocortin receptor types, it also affects appetite and sexual desire
Studies exploring tendon healing, muscle injury models, and angiogenesis pathways have contributed to a growing body of literature, but this research has not progressed to human clinical trials, and BPC-157 is not approved by the FDA for any human or veterinary use
Yes, glutathione can indeed brighten skin by inhibiting tyrosinase, the enzyme involved in melanin production
A more recent analysis focused on neuropathy found improvements in pain, some nerve conduction tests, and reduced swelling of nerves
Es seguro el GHK-Cu en piel sensible o roscea
Topical makes the most sense for: Facial skin texture, fine lines, hydration Scalp application for localized hair growth Scar treatment or post-procedure recovery on a specific area Patients who want to fold GHK-Cu into an existing skincare routine Injectable makes the most sense for: Systemic wound healing (especially internal or in areas you can't easily apply cream) Joint and connective tissue support (topical simply can't penetrate deep enough) Broader anti-aging goals beyond the skin surface Patients already running other injectable peptide protocols (CJC-1295/ipamorelin, BPC-157, TB-500) Here's the thing: for joints specifically, there's no argument